The Patent Finder

Cellestis Pty Ltd.

Also on record
Records under this name other than patents Cellestis Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cellestis Pty Ltd.

PatentTitleStatus Expires Confidence
US 8,871,508Cell-mediated immune response assay and kits therefor
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,110,061Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,829,490Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,408,833Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,788,491Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,275,086Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,181,476Use of Amino Acid Sequences from Mycobacterium Tuberculosis or Corresponding Nucleic Acids for Diagnosis and Prevention of Tubercular Infection, Diagnostic Kit and Vaccine Therefrom
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,459,253Assay for measuring cell-mediated immunoresponsiveness
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,551,380TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,578,612Diagnostic assay
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited